PSTV (Cytori Therapeutics) Wutah bathi resik saben saham ing taun iki

How is Plus Therapeutics, Inc. (PSTV) combating brain cancer? Management is focusing on validating the efficacy of new radiotherapeutic methods. Year-over-year EPS growth reflects a trend where the parameter value equals 45.70. Stability is provided by a neutral US geopolitical backdrop and a network of specialized hubs for ultra-precise isotope delivery, which supports high business margins.

Wutah bathi saben saham ing taun lumaku: Cytori Therapeutics (PSTV) kanggo 04.07.2022 - 03.08.2026

Rincian analitis lan laporan data perusahaan plustherapeutics.com (PSTV)

- kuotasi lan prakiraan analis:

Kurs saham Plus Therapeutics|PSTV - Prakiraan konsensus analis

- indikator valuasi pasar bisnis:

Biji pasar PSTV|PSTV - Nilai Perusahaan

- rincian nilai buku perusahaan:

Nilai Aset Bersih saben Saham Plus Therapeutics|PSTV - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku plustherapeutics.com|PSTV - Aset Agregat Perusahaan

- indikator beban utang lan likuiditas:

Utang Agregat marang Ekuitas Plus Therapeutics, Inc.|PSTV - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Plus Therapeutics|PSTV - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku PSTV|PSTV - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Plus Therapeutics|Rasio jangkoan perantara plustherapeutics.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

PSTV - Penghasilan resik|Bathi resik mangsa ngarep Plus Therapeutics, Inc.|PSTV - Pangali P/E|Pangali mangsa ngarep rega marang bathi Plus Therapeutics|PSTV - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan PSTV|PSTV - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Plus Therapeutics|PSTV - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan plustherapeutics.com|PSTV - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Plus Therapeutics, Inc.

- data pendapatan lan penerimaan dodolan:

PSTV - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan Plus Therapeutics|PSTV - Kapitalisasi marang pendapatan|Multiplikator Forward P/S PSTV

Ringkesan analisis perusahaan:Plus Therapeutics, Inc.

This indicator measures the year-over-year dynamics of earnings per share, reflecting the efficiency of capital generation. A stable upward trend in the annual EPS growth rate confirms the business's fundamental resilience to macroeconomic shocks. Investors should evaluate the rate of profit change as a marker of asset management quality. For Plus Therapeutics, Inc. (PSTV), this metric reflects the commercial success of implementing radiopharmaceuticals in neuro-oncology. The growth of this metric confirms the scaling of targeted isotope delivery technology within the nuclear medicine market.

Pesaing utama

Wutah bathi saben saham ing taun iki OLMA|PBYI (Puma Bio) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Greenwich LifeSciences Inc (GLSI)|Wutah bathi ing taun lumaku ZNTL|MGNX - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Processa Pharmaceuticals, Inc. PCSA|Tambahing bathi saben saham ing taun lumaku EGRX